Company: INKT
Filing Date: 2025-07-15
Form Type: 8-K
Source: 0001193125-25-159017
Chunk: 1

Company: MiNK Therapeutics, Inc.
Filing Date: 2025-07-15
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

  Exhibit      Description                                                                                                                   
                                                                                                                                             
      No.                                                                                                                                    
      1.1      At Market Issuance Sales Agreement, dated as of July 15, 2025, between MiNK Therapeutics, Inc. and B. Riley Securities, Inc.  
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
      5.1      Opinion of Latham & Watkins LLP                                                                                               
     23.1      Consent of Latham & Watkins LLP (contained in Exhibit 5.1)                                                                    
      104      Cover Page Interactive Data File (embedded within the Inline XBRL document)                                                   

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                           MINK THERAPEUTICS, INC.                                       
  Date: July 15, 2025      By:                          /s/ Jennifer S. Buell, Ph. D.    
                                                        Name: Jennifer S. Buell, Ph. D.